Asia PR News

PLEASANTON, Calif., March 28 /PRNewswire-AsiaNet/ –

ProPharma Partners, Inc. and Biolink International, Inc. have formed a
partnership in order to broaden their business development and strategic
advisory expertise globally. As a result of the partnership, the two firms have
strengthened and expanded services to the pharmaceutical and biotechnology
industries at the local, regional and global level in the major pharmaceutical
markets of Japan & Asia, Europe and North America.

ProPharma International Partners and Biolink International client
companies now have access to a greater range of advisory services and
expertise as well as seamless access to products, technologies and potential
partners throughout the major pharmaceutical markets.

ProPharma International Partners with locations in London and the San
Francisco Bay area in California, and Biolink International Inc., located in
Tokyo have an extensive record of successfully providing a range of services
including:

— Product and technology in-licensing/ out-licensing and acquisitions
— Strategic business and product development consulting
— Business and product due diligence, IP assessment and valuation
modeling
— An affiliated team of individuals with expertise in preclinical,
pharmacokinetics, CMC, clinical and regulatory affairs to assist in
defining and implementing drug development plans.

For more information please visit www.ProPharmaip.com.

Contact: James Chubb, Partner
ProPharma International Partners, Inc.
jchubb@propharmaip.com
510-681-4445

SOURCE: ProPharma Partners, Inc.

CONTACT:
James Chubb
Partner of ProPharma International Partners, Inc.,
+1-510-681-4445, or
jchubb@propharmaip.com
Web site: http://www.propharmaip.com